Histamine stimulates human microglia to alter cellular prion protein expression via the HRH2 histamine receptor.
Degranulation
Histamine
Mast cell
Microglia
Neuroinflammation
Prion protein
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
26 Oct 2024
26 Oct 2024
Historique:
received:
05
06
2024
accepted:
09
10
2024
medline:
27
10
2024
pubmed:
27
10
2024
entrez:
27
10
2024
Statut:
epublish
Résumé
Although the cellular prion protein (PrP
Identifiants
pubmed: 39462031
doi: 10.1038/s41598-024-75982-1
pii: 10.1038/s41598-024-75982-1
doi:
Substances chimiques
Histamine
820484N8I3
Receptors, Histamine H2
0
Calcium
SY7Q814VUP
PrPC Proteins
0
Cytokines
0
Receptors, Histamine
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
25519Informations de copyright
© 2024. Crown.
Références
Nimmerjahn, A., Kirchhoff, F. & Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308(5726), 1314–1318 (2005).
pubmed: 15831717
doi: 10.1126/science.1110647
Kyrargyri, V. et al. P2Y(13) receptors regulate microglial morphology, surveillance, and resting levels of interleukin 1β release. Glia 68(2), 328–344 (2020).
pubmed: 31520551
doi: 10.1002/glia.23719
Dong, H. et al. Histamine induces upregulated expression of histamine receptors and increases release of inflammatory mediators from microglia. Mol. Neurobiol. 49(3), 1487–1500 (2014).
pubmed: 24752587
doi: 10.1007/s12035-014-8697-6
Sandhu, J. K., Kulka, M. Decoding mast cell-microglia communication in neurodegenerative diseases. Int. J. Mol. Sci. 22(3), (2021).
Scammell, T. E., Jackson, A. C., Franks, N. P., Wisden, W., Dauvilliers, Y. Histamine: Neural circuits and new medications. Sleep. 42(1), (2019).
Akdis, C. A. & Simons, F. E. Histamine receptors are hot in immunopharmacology. Eur. J. Pharmacol. 533(1–3), 69–76 (2006).
pubmed: 16448645
doi: 10.1016/j.ejphar.2005.12.044
Shi, Z. et al. Distinct roles of histamine H1- and H2-receptor signaling pathways in inflammation-associated colonic tumorigenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 316(1), G205–G216 (2019).
pubmed: 30462522
doi: 10.1152/ajpgi.00212.2018
Hofstra, C. L., Desai, P. J., Thurmond, R. L. & Fung-Leung, W. P. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 305(3), 1212–1221 (2003).
pubmed: 12626656
doi: 10.1124/jpet.102.046581
Thurmond, R. L. The histamine H4 receptor: From orphan to the clinic. Front. Pharmacol. 6, 65 (2015).
pubmed: 25873897
pmcid: 4379874
doi: 10.3389/fphar.2015.00065
Zhang, W. et al. Histamine induces microglia activation and the release of proinflammatory mediators in rat brain via H(1)R or H(4)R. J. Neuroimmune Pharmacol. 15(2), 280–291 (2020).
pubmed: 31863333
doi: 10.1007/s11481-019-09887-6
Lin, C. J. et al. Mast cell deficiency improves cognition and enhances disease-associated microglia in 5XFAD mice. Cell Rep. 42(9), 113141 (2023).
pubmed: 37713312
doi: 10.1016/j.celrep.2023.113141
Ramírez-Ponce, M. P. et al. Mast cell changes the phenotype of microglia via histamine and ATP. Cell Physiol. Biochem. 55(1), 17–32 (2021).
pubmed: 33443845
doi: 10.33594/000000324
Ferreira, R. et al. Histamine modulates microglia function. J. Neuroinflammation 9, 90 (2012).
pubmed: 22569158
pmcid: 3583187
doi: 10.1186/1742-2094-9-90
Rocha, S. M., Pires, J., Esteves, M., Graça, B. & Bernardino, L. Histamine: A new immunomodulatory player in the neuron-glia crosstalk. Front. Cell Neurosci. 8, 120 (2014).
pubmed: 24817841
pmcid: 4012198
doi: 10.3389/fncel.2014.00120
Rocha, S. M. et al. Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation. J. Neuroinflammation 13(1), 137 (2016).
pubmed: 27260166
pmcid: 4893260
doi: 10.1186/s12974-016-0600-0
Bader, M. F., Taupenot, L., Ulrich, G., Aunis, D. & Ciesielski-Treska, J. Bacterial endotoxin induces [Ca2+]i transients and changes the organization of actin in microglia. Glia 11(4), 336–344 (1994).
pubmed: 7525480
doi: 10.1002/glia.440110406
Xia, P., Logiacco, F., Huang, Y., Kettenmann, H. & Semtner, M. Histamine triggers microglial responses indirectly via astrocytes and purinergic signaling. Glia 69(9), 2291–2304 (2021).
pubmed: 34080730
doi: 10.1002/glia.24039
Iida, T. et al. Histamine H3 receptor in primary mouse microglia inhibits chemotaxis, phagocytosis, and cytokine secretion. Glia 63(7), 1213–1225 (2015).
pubmed: 25754956
doi: 10.1002/glia.22812
Kitamoto, T. et al. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am. J. Pathol. 140(6), 1285–1294 (1992).
pubmed: 1351366
pmcid: 1886543
Shi, F. et al. Prion protein participates in the regulation of classical and alternative activation of BV2 microglia. J. Neurochem. 124(2), 168–174 (2013).
pubmed: 23061439
doi: 10.1111/jnc.12053
Hou, F. et al. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146(3), 448–461 (2011).
pubmed: 21782231
pmcid: 3179916
doi: 10.1016/j.cell.2011.06.041
Isaacs, J. D., Jackson, G. S. & Altmann, D. M. The role of the cellular prion protein in the immune system. Clin. Exp. Immunol. 146(1), 1–8 (2006).
pubmed: 16968391
pmcid: 1809729
doi: 10.1111/j.1365-2249.2006.03194.x
Willows, S. D. et al. Mast cell proteases cleave prion proteins and a recombinant Ig against PrP can activate human mast cells. J. Immunol. 210(9), 1447–1458 (2023).
pubmed: 36939393
doi: 10.4049/jimmunol.2200726
Rivera-Milla, E. et al. Disparate evolution of prion protein domains and the distinct origin of Doppel- and prion-related loci revealed by fish-to-mammal comparisons. Faseb J. 20(2), 317–319 (2006).
pubmed: 16352647
doi: 10.1096/fj.05-4279fje
Haddon, D. J. et al. Prion protein expression and release by mast cells after activation. J. Infect. Dis. 200(5), 827–831 (2009).
pubmed: 19642931
doi: 10.1086/605022
Lee, Y. J. & Baskakov, I. V. The cellular form of the prion protein is involved in controlling cell cycle dynamics, self-renewal, and the fate of human embryonic stem cell differentiation. J. Neurochem. 124(3), 310–322 (2013).
pubmed: 22860629
doi: 10.1111/j.1471-4159.2012.07913.x
Aguzzi, A. & Polymenidou, M. Mammalian prion biology: One century of evolving concepts. Cell 116(2), 313–327 (2004).
pubmed: 14744440
doi: 10.1016/S0092-8674(03)01031-6
Zeng, L., Zou, W. & Wang, G. Cellular prion protein (PrP(C)) and its role in stress responses. Int. J. Clin. Exp. Med. 8(5), 8042–8050 (2015).
pubmed: 26221369
pmcid: 4509314
Bai, Y., Li, Y. R., Wang, G. H., Zhou, X. M. & Zhao, D. M. PrP 106–126 altered PrP mRNA gene expression in mouse microglia BV-2 cells. Virol. Sin. 25(6), 440–444 (2010).
pubmed: 21221923
doi: 10.1007/s12250-010-3143-z
Ding, T. et al. Cellular prion protein participates in the regulation of inflammatory response and apoptosis in BV2 microglia during infection with Mycobacterium bovis. J. Mol. Neurosci. 51(1), 118–126 (2013).
pubmed: 23345082
doi: 10.1007/s12031-013-9962-2
Brown, D. R., Besinger, A., Herms, J. W. & Kretzschmar, H. A. Microglial expression of the prion protein. Neuroreport 9(7), 1425–1429 (1998).
pubmed: 9631441
doi: 10.1097/00001756-199805110-00032
Montilla, A., Zabala, A., Matute, C. & Domercq, M. Functional and metabolic characterization of microglia culture in a defined medium. Front. Cell Neurosci. 14, 22 (2020).
pubmed: 32116565
pmcid: 7025516
doi: 10.3389/fncel.2020.00022
Nemani, S. K. et al. A novel mechanism of phenotypic heterogeneity in Creutzfeldt-Jakob disease. Acta Neuropathol. Commun. 8(1), 85 (2020).
pubmed: 32560672
pmcid: 7304206
doi: 10.1186/s40478-020-00966-x
Wagner, A., Pehar, M., Yan, Z. & Kulka, M. Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia. Front. Pharmacol. 14, 1102465 (2023).
pubmed: 37124206
pmcid: 10130647
doi: 10.3389/fphar.2023.1102465
Reddaway, J., Richardson, P. E., Bevan, R. J., Stoneman, J. & Palombo, M. Microglial morphometric analysis: So many options, so little consistency. Front. Neuroinform. 17, 1211188 (2023).
pubmed: 37637472
pmcid: 10448193
doi: 10.3389/fninf.2023.1211188
Müller, T. et al. Functional characterization of histamine receptor subtypes in a human bronchial epithelial cell line. Int. J. Mol. Med. 18(5), 925–931 (2006).
pubmed: 17016623
Thangam, E. B. et al. The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: The hunt for new therapeutic targets. Front. Immunol. 9, 1873 (2018).
pubmed: 30150993
pmcid: 6099187
doi: 10.3389/fimmu.2018.01873
Connelly, W. M. et al. The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS. Br. J. Pharmacol. 157(1), 55–63 (2009).
pubmed: 19413571
pmcid: 2697783
doi: 10.1111/j.1476-5381.2009.00227.x
Jin, C. Y. & Panula, P. The laminar histamine receptor system in human prefrontal cortex suggests multiple levels of histaminergic regulation. Neuroscience 132(1), 137–149 (2005).
pubmed: 15780473
doi: 10.1016/j.neuroscience.2004.12.017
Sharma, P. & Ping, L. Calcium ion influx in microglial cells: Physiological and therapeutic significance. J. Neurosci. Res. 92(4), 409–423 (2014).
pubmed: 24464907
doi: 10.1002/jnr.23344
Hopperton, K. E., Mohammad, D., Trépanier, M. O., Giuliano, V. & Bazinet, R. P. Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: A systematic review. Mol. Psychiatry 23(2), 177–198 (2018).
pubmed: 29230021
doi: 10.1038/mp.2017.246
Ito, D. et al. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res. Mol. Brain Res. 57(1), 1–9 (1998).
pubmed: 9630473
doi: 10.1016/S0169-328X(98)00040-0
Linden, R. The biological function of the prion protein: A cell surface scaffold of signaling modules. Front. Mol. Neurosci. 10, 77 (2017).
pubmed: 28373833
pmcid: 5357658
doi: 10.3389/fnmol.2017.00077
Pasala, C. et al. N-Glycosylation as a modulator of protein conformation and assembly in disease. Biomolecules 14(3), 282 (2024).
pubmed: 38540703
pmcid: 10968129
doi: 10.3390/biom14030282
Chai, Q. et al. HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration. Nat. Commun. 8(1), 1522 (2017).
pubmed: 29142315
pmcid: 5688069
doi: 10.1038/s41467-017-01795-8
Gupta, M. K., Behera, S. K., Dehury, B. & Mahapatra, N. Identification and characterization of differentially expressed genes from human microglial cell samples infected with Japanese encephalitis virus. J. Vector Borne Dis. 54(2), 131–138 (2017).
pubmed: 28748833
doi: 10.4103/0972-9062.211687
Hjorth, E. et al. Omega-3 fatty acids enhance phagocytosis of Alzheimer’s disease-related amyloid-β42 by human microglia and decrease inflammatory markers. J. Alzheimers Dis. 35(4), 697–713 (2013).
pubmed: 23481688
doi: 10.3233/JAD-130131
Dello Russo, C. et al. The human microglial HMC3 cell line: Where do we stand? A systematic literature review. J. Neuroinflammation 15(1), 259 (2018).
doi: 10.1186/s12974-018-1288-0
Wang, Y. J., Monteagudo, A., Downey, M. A., Ashton-Rickardt, P. G. & Elmaleh, D. R. Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3). Sci. Rep. 11(1), 8054 (2021).
pubmed: 33850164
pmcid: 8044132
doi: 10.1038/s41598-021-85702-8
Ehrlich, L. C. et al. Cytokine regulation of human microglial cell IL-8 production. J. Immunol. 160(4), 1944–1948 (1998).
pubmed: 9469457
doi: 10.4049/jimmunol.160.4.1944
Kaur, D., Sharma, V. & Deshmukh, R. Activation of microglia and astrocytes: A roadway to neuroinflammation and Alzheimer’s disease. Inflammopharmacology 27(4), 663–677 (2019).
pubmed: 30874945
doi: 10.1007/s10787-019-00580-x
Govindarajan, V., de Rivero Vaccari, J. P. & Keane, R. W. Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets. J. Neuroinflammation 17(1), 260 (2020).
pubmed: 32878648
pmcid: 7469327
doi: 10.1186/s12974-020-01944-9
Zimmermann, H. W. et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS One 6(6), e21381 (2011).
pubmed: 21731723
pmcid: 3120868
doi: 10.1371/journal.pone.0021381
Walker, D. G., Lue, L. F. & Beach, T. G. Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol. Aging 22(6), 957–966 (2001).
pubmed: 11755004
doi: 10.1016/S0197-4580(01)00306-2
Flynn, G., Maru, S., Loughlin, J., Romero, I. A. & Male, D. Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 136(1–2), 84–93 (2003).
pubmed: 12620646
doi: 10.1016/S0165-5728(03)00009-2
Hickman, S. E., Allison, E. K., Coleman, U., Kingery-Gallagher, N. D. & El Khoury, J. Heterozygous CX3CR1 deficiency in microglia restores neuronal β-amyloid clearance pathways and slows progression of Alzheimer’s like-disease in PS1-APP mice. Front. Immunol. 10, 2780 (2019).
pubmed: 31849963
pmcid: 6900980
doi: 10.3389/fimmu.2019.02780
Erta, M., Quintana, A. & Hidalgo, J. Interleukin-6, a major cytokine in the central nervous system. Int. J. Biol. Sci. 8(9), 1254–1266 (2012).
pubmed: 23136554
pmcid: 3491449
doi: 10.7150/ijbs.4679
Willis, E. F. et al. Repopulating microglia promote brain repair in an IL-6-dependent manner. Cell 180(5), 833–46.e16 (2020).
pubmed: 32142677
doi: 10.1016/j.cell.2020.02.013
Garner, K. M., Amin, R., Johnson, R. W., Scarlett, E. J. & Burton, M. D. Microglia priming by interleukin-6 signaling is enhanced in aged mice. J. Neuroimmunol. 324, 90–99 (2018).
pubmed: 30261355
pmcid: 6699492
doi: 10.1016/j.jneuroim.2018.09.002
Sébire, G. et al. In vitro production of IL-6, IL-1 beta, and tumor necrosis factor-alpha by human embryonic microglial and neural cells. J. Immunol. 150(4), 1517–1523 (1993).
pubmed: 8432992
doi: 10.4049/jimmunol.150.4.1517
Deber, C. M., Tom-Kun, J., Mack, E. & Grinstein, S. Bromo-A23187: A nonfluorescent calcium ionophore for use with fluorescent probes. Anal. Biochem. 146(2), 349–352 (1985).
pubmed: 3927770
doi: 10.1016/0003-2697(85)90550-0
Kettenmann, H., Hanisch, U. K., Noda, M. & Verkhratsky, A. Physiology of microglia. Physiol. Rev. 91(2), 461–553 (2011).
pubmed: 21527731
doi: 10.1152/physrev.00011.2010
Shi, F. J. et al. Is Iba-1 protein expression a sensitive marker for microglia activation in experimental diabetic retinopathy?. Int. J. Ophthalmol. 14(2), 200–208 (2021).
pubmed: 33614447
pmcid: 7840370
doi: 10.18240/ijo.2021.02.04
Yusoff, M., Hashim, N. H. & Mohd-Yusuf, Y. Detection of histamine receptors on mouse oocytes and their involvement in fertilization potential. Vet. Res. Forum 13(3), 331–337 (2022).
pubmed: 36320314
pmcid: 9548215
Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34(36), 11929–11947 (2014).
pubmed: 25186741
pmcid: 4152602
doi: 10.1523/JNEUROSCI.1860-14.2014
Zhang, C. C., Steele, A. D., Lindquist, S. & Lodish, H. F. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc. Natl. Acad. Sci. U S A. 103(7), 2184–2189 (2006).
pubmed: 16467153
pmcid: 1413720
doi: 10.1073/pnas.0510577103
Ballerini, C. et al. Functional implication of cellular prion protein in antigen-driven interactions between T cells and dendritic cells. J. Immunol. 176(12), 7254–7262 (2006).
pubmed: 16751368
doi: 10.4049/jimmunol.176.12.7254
Dürig, J. et al. Differential constitutive and activation-dependent expression of prion protein in human peripheral blood leucocytes. Br. J. Haematol. 108(3), 488–495 (2000).
pubmed: 10759704
doi: 10.1046/j.1365-2141.2000.01881.x
Carroll, J. A., Race, B., Williams, K., Striebel, J., & Chesebro, B. Microglia are critical in host defense against prion disease. J Virol. 92(15), (2018).
Gómez-Nicola, D., Fransen, N. L., Suzzi, S. & Perry, V. H. Regulation of microglial proliferation during chronic neurodegeneration. J. Neurosci. 33(6), 2481–2493 (2013).
pubmed: 23392676
pmcid: 6619184
doi: 10.1523/JNEUROSCI.4440-12.2013
Wang, Y., Hartmann, K., Thies, E., Mohammadi, B., Altmeppen, H., Sepulveda-Falla, D., et al. Loss of homeostatic microglia signature in prion diseases. Cells. 11(19), (2022).
Thomas, D. M., Francescutti-Verbeem, D. M. & Kuhn, D. M. Gene expression profile of activated microglia under conditions associated with dopamine neuronal damage. Faseb J. 20(3), 515–517 (2006).
pubmed: 16384912
doi: 10.1096/fj.05-4873fje
Vergara, D., Nigro, A., Romano, A., De Domenico, S., Damato, M., Franck, J., et al. Distinct protein expression networks are activated in microglia cells after stimulation with IFN-γ and IL-4. Cells. 8(6), (2019).
Pinheiro, L. P., Linden, R. & Mariante, R. M. Activation and function of murine primary microglia in the absence of the prion protein. J Neuroimmunol. 286, 25–32 (2015).
pubmed: 26298321
doi: 10.1016/j.jneuroim.2015.07.002
Izzy, S. et al. Time-dependent changes in microglia transcriptional networks following traumatic brain injury. Front. Cell Neurosci. 13, 307 (2019).
pubmed: 31440141
pmcid: 6694299
doi: 10.3389/fncel.2019.00307
Do, H. N., Haldane, A., Levy, R. M. & Miao, Y. Unique features of different classes of G-protein-coupled receptors revealed from sequence coevolutionary and structural analysis. Proteins 90(2), 601–614 (2022).
pubmed: 34599827
doi: 10.1002/prot.26256
Alavi, M. S., Shamsizadeh, A., Azhdari-Zarmehri, H. & Roohbakhsh, A. Orphan G protein-coupled receptors: The role in CNS disorders. Biomed. Pharmacother. 98, 222–232 (2018).
pubmed: 29268243
doi: 10.1016/j.biopha.2017.12.056
Azam, S., Haque, M. E., Jakaria, M., Jo, S. H., Kim, I. S., & Choi, D. K. G-Protein-coupled receptors in CNS: A potential therapeutic target for intervention in neurodegenerative disorders and associated cognitive deficits. Cells. 9(2), (2020).
Wong, T. S. et al. G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. Signal Transduct. Target Ther. 8(1), 177 (2023).
pubmed: 37137892
pmcid: 10154768
doi: 10.1038/s41392-023-01427-2
Ghosh, M. et al. Proinflammatory cytokine regulation of cyclic AMP-phosphodiesterase 4 signaling in microglia in vitro and following CNS injury. Glia 60(12), 1839–1859 (2012).
pubmed: 22865690
pmcid: 4383287
doi: 10.1002/glia.22401
Sobolczyk, M. & Boczek, T. Astrocytic calcium and cAMP in neurodegenerative diseases. Front. Cell Neurosci. 16, 889939 (2022).
pubmed: 35663426
pmcid: 9161693
doi: 10.3389/fncel.2022.889939
Nuutinen, S. & Panula, P. Histamine in neurotransmission and brain diseases. Adv. Exp. Med. Biol. 709, 95–107 (2010).
pubmed: 21618891
doi: 10.1007/978-1-4419-8056-4_10
Roguski, A., & Gill, A. C. The role of the mammalian prion protein in the control of sleep. Pathogens. 6(4), (2017).
Peggion, C., Stella, R., Lorenzon, P., Spisni, E., Bertoli, A., & Massimino, M. L. Microglia in prion diseases: Angels or demons? Int. J. Mol. Sci. 21(20), (2020).
Wu, G. R. et al. Prion protein is required for tumor necrosis factor α (TNFα)-triggered nuclear factor κB (NF-κB) signaling and cytokine production. J. Biol. Chem. 292(46), 18747–18759 (2017).
pubmed: 28900035
pmcid: 5704461
doi: 10.1074/jbc.M117.787283
Linden, R. et al. Physiology of the prion protein. Physiol. Rev. 88(2), 673–728 (2008).
pubmed: 18391177
doi: 10.1152/physrev.00007.2007
Fournier, J. G., Escaig-Haye, F. & Grigoriev, V. Ultrastructural localization of prion proteins: Physiological and pathological implications. Microsc. Res. Tech. 50(1), 76–88 (2000).
pubmed: 10871551
doi: 10.1002/1097-0029(20000701)50:1<76::AID-JEMT11>3.0.CO;2-#
Wulf, M. A., Senatore, A. & Aguzzi, A. The biological function of the cellular prion protein: An update. BMC Biol. 15(1), 34 (2017).
pubmed: 28464931
pmcid: 5412054
doi: 10.1186/s12915-017-0375-5
Herms, J. et al. Evidence of presynaptic location and function of the prion protein. J. Neurosci. 19(20), 8866–8875 (1999).
pubmed: 10516306
pmcid: 6782778
doi: 10.1523/JNEUROSCI.19-20-08866.1999
Kovač, V., & Čurin Šerbec, V. Prion protein: The molecule of many forms and faces. Int. J. Mol. Sci. 23(3), (2022).
Bendheim, P. E. et al. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology 42(1), 149–156 (1992).
pubmed: 1346470
doi: 10.1212/WNL.42.1.149
Strom, A. et al. Cellular prion protein localizes to the nucleus of endocrine and neuronal cells and interacts with structural chromatin components. Eur. J. Cell Biol. 90(5), 414–419 (2011).
pubmed: 21277044
doi: 10.1016/j.ejcb.2010.11.015
DeArmond, S. J. et al. Changes in the localization of brain prion proteins during scrapie infection. Neurology 37(8), 1271–1280 (1987).
pubmed: 3112607
doi: 10.1212/WNL.37.8.1271
Lu, Y. C., Yeh, W. C. & Ohashi, P. S. LPS/TLR4 signal transduction pathway. Cytokine 42(2), 145–151 (2008).
pubmed: 18304834
doi: 10.1016/j.cyto.2008.01.006
Wang, D. et al. Molecular mechanism of antihistamines recognition and regulation of the histamine H(1) receptor. Nat. Commun. 15(1), 84 (2024).
pubmed: 38167898
pmcid: 10762250
doi: 10.1038/s41467-023-44477-4
Miranzadeh Mahabadi, H., & Taghibiglou, C. Cellular prion protein (PrPc): Putative interacting partners and consequences of the interaction. Int. J. Mol. Sci. 21(19), (2020).
Westergard, L., Christensen, H. M. & Harris, D. A. The cellular prion protein (PrP(C)): Its physiological function and role in disease. Biochim. Biophys. Acta. 1772(6), 629–644 (2007).
pubmed: 17451912
pmcid: 1986710
doi: 10.1016/j.bbadis.2007.02.011